title: Neuroleptic malignant syndrome induced by blonanserin.
authors.forename: Keiko
authors.initials: K
authors.lastname: Ohoyama
authors.forename: Hisashi
authors.initials: H
authors.lastname: Tanii
authors.forename: Eishi
authors.initials: E
authors.lastname: Motomura
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Konishi
authors.forename: Masanori
authors.initials: M
authors.lastname: Nakagawa
authors.forename: Takuya
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Takashi
authors.initials: T
authors.lastname: Shiroyama
authors.forename: Motohiro
authors.initials: M
authors.lastname: Okada
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000523:psychology*; D010879:Piperazines / Q000009:adverse effects*; D010880:Piperidines / Q000009:adverse effects*
chemical_list: D010879:Piperazines; D010880:Piperidines; C079310:blonanserin